featured
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
JAMA Dermatol 2023 Apr 12;[EPub Ahead of Print], AS Paller, B Ladizinski, P Mendes-Bastos, E Siegfried, W Soong, VH Prajapati, P Lio, JP Thyssen, EL Simpson, AM Platt, EM Raymundo, J Liu, BM Calimlim, X Huang, Y Gu, X Hu, Y Yang, JC Su, M Zheng, K Yamamoto-Hanada, HD Teixeira, AD IrvineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.